Redefining the Standard of Care: The PROGRESS Trial Challenges the "Wait and See" Approach to Moderate Aortic Stenosis on November 3, 2026 Posted by
Decoding the Immune Stalemate: A New Frontier in Treating Chronic Diabetic Ulcers on November 3, 2026 Posted by
NewYork-Presbyterian and Spear Forge Landmark Partnership to Revolutionize Outpatient Rehabilitation Access Across NYC and Westchester on November 3, 2026 Posted by
Beyond the Salt Shaker: Why Potassium is the Missing Link in Global Heart Health on November 3, 2026 Posted by
Navigating the Future of Nutrition: A Comprehensive Review of the 2022-2023 Healthy Living Landscape on November 3, 2026 Posted by
Redefining the Standard of Care: The PROGRESS Trial Challenges the "Wait and See" Approach to Moderate Aortic Stenosis on November 3, 2026 Posted by
Decoding the Immune Stalemate: A New Frontier in Treating Chronic Diabetic Ulcers on November 3, 2026 Posted by
NewYork-Presbyterian and Spear Forge Landmark Partnership to Revolutionize Outpatient Rehabilitation Access Across NYC and Westchester on November 3, 2026 Posted by
Posted in Mental Health Recovery Empowering the Next Generation: How a Historic $20 Million Gift and Youth-Led Advocacy are Transforming the Mental Health Landscape on September 5, 2026
Posted in Medical Innovations Biotech Industry Update: From Historic Rare Disease Breakthroughs to Strategic Restructuring on September 4, 2026
Posted in Medical Innovations A New Dawn for Alexander Disease: FDA Grants Historic Approval to Zilganersen on September 4, 2026
Posted in Digital Health Tools A Breakthrough for the Ultra-Rare: FDA Grants Historic Approval to Ionis Pharmaceuticals for Alexander Disease Treatment on September 4, 2026
Posted in Medical Innovations A New Dawn for Rare Disease: Ionis Pharmaceuticals Secures Historic FDA Approval for Alexander Disease Therapy on September 3, 2026
Posted in Mental Health Recovery A Defining Moment for Youth Mental Health: Active Minds Receives Historic $20 Million Gift from MacKenzie Scott on August 30, 2026
Posted in Digital Health Tools A New Era for Dermatomyositis: Roivant Sciences Secures Historic FDA Approval for Lisraya on August 28, 2026
Posted in Medical Innovations A Historic Milestone in Oncology: Revolution Medicines Launches Rasonque for Metastatic Pancreatic Cancer on August 27, 2026
Posted in Digital Health Tools A Paradigm Shift in Oncology: Moderna and Merck’s mRNA Cancer Therapy Hits Historic Phase 3 Milestone on August 27, 2026
Posted in Medical Innovations The Double-Edged Sword: Employers Retreat from GLP-1 Coverage Amid Biotech’s Historic Workforce Contraction on August 27, 2026
